Maxamine Melanoma Liver Subset Needs More Focused Study - FDA Cmte.
Executive Summary
Maxim would have to conduct a new, larger study focused solely on metastatic melanoma that has spread to the liver in order to support approval of Maxamine, FDA's Oncologic Drugs Advisory Committee suggested Dec. 13.